All Curated Mutation Sites in IV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in IV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
HA1
  
HA2
  
M1
  
M2
  
NA
  
NP
  
NS1
  
NS2
  
PA
  
PB1
  
PB2
  

Keyword: Influenza A-23397331
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 23397331 H275Y
NA
NA
Influenza A
D
G
S
C
L
View
2 23397331 E374K
HA2
HA
Influenza A
G
S
C
L
View
3 23397331 I321V
HA2
HA
Influenza A
G
S
C
L
View
4 23397331 P83S
HA1
HA
Influenza A
G
S
C
L
View
5 23397331 S203T
HA1
HA
Influenza A
G
S
C
L
View
6 23397331 A134T
HA
HA
Influenza A
G
S
C
L
View
7 23397331 A197T
HA
HA
Influenza A
G
S
C
L
View
8 23397331 D97N
HA
HA
Influenza A
G
S
C
L
View
9 23397331 H138Q
HA
HA
Influenza A
G
S
C
L
View
10 23397331 I216V
HA
HA
Influenza A
G
S
C
L
View
11 23397331 K119N
HA
HA
Influenza A
G
S
C
L
View
12 23397331 K130R
HA
HA
Influenza A
G
S
C
L
View
13 23397331 M344L
HA
HA
Influenza A
G
S
C
L
View
14 23397331 N125D
HA
HA
Influenza A
G
S
C
L
View
15 23397331 N31D
HA
HA
Influenza A
G
S
C
L
View
16 23397331 P159S
HA
HA
Influenza A
G
S
C
L
View
17 23397331 R205K
HA
HA
Influenza A
G
S
C
L
View
18 23397331 S143G
HA
HA
Influenza A
G
S
C
L
View
19 23397331 S162N
HA
HA
Influenza A
G
S
C
L
View
20 23397331 S183P
HA
HA
Influenza A
G
S
C
L
View
21 23397331 S185T
HA
HA
Influenza A
G
S
C
L
View
22 23397331 S84I
HA
HA
Influenza A
G
S
C
L
View
23 23397331 V249L
HA
HA
Influenza A
G
S
C
L
View
Contents
Description

The table shows all curated mutation sites of IV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.